Cart
sales@molnova.com
Carbazeran
CAS No. 70724-25-3
Carbazeran( UK 31557 | UK-31557 | UK31557 | UK 31,557 | UK-31,557 | UK31,557 | )
Catalog No. M27410 CAS No. 70724-25-3
Carbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 265 | In Stock |
|
| 100MG | 398 | In Stock |
|
| 200MG | 615 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarbazeran
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
DescriptionCarbazeran is an inhibitor of PDE2 and PDE3 and can be used for studies about metabolic diseases. Carbazeran shows inotropic and chronotropic effects in vivo(EC50 = 100 μM).
-
In Vitro——
-
In Vivo——
-
SynonymsUK 31557 | UK-31557 | UK31557 | UK 31,557 | UK-31,557 | UK31,557 |
-
PathwayAngiogenesis
-
TargetPDE
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number70724-25-3
-
Formula Weight360.414
-
Molecular FormulaC18H24N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 125 mg/mL (346.83 mM)
-
SMILESCCNC(=O)OC1CCN(CC1)c1nncc2cc(OC)c(OC)cc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jean-Louis H. Dasseux, et al. Ketone compounds and compositions for cholesterol management and related uses. WO2002030860A2.
molnova catalog
related products
-
Mardepodect
A potent and selective PDE10A inhibitor with IC50 of 0.37 nM.
-
BI 1015550
Nerandomilast (BI 1015550) is an orally active PDE4B inhibitor with IC50 of 7.2 nM. BI 1015550 has potential applications in inflammation, allergic diseases, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD) with a good safety profile.
-
EMD57439
EMD57439 is a selective PDE-III inhibitor, showing no significant increase in c-AMP concentration and producing little change in Ca(50).
